Regulation of Cardiac Remodeling by Cardiac Na(+)/K(+)-ATPase Isoforms.
Cardiac remodeling occurs after cardiac pressure/volume overload or myocardial injury during the development of heart failure and is a determinant of heart failure. Preventing or reversing remodeling is a goal of heart failure therapy. Human cardiomyocyte Na(+)/K(+)-ATPase has multiple α isoforms (1-3). The expression of the α subunit of the Na(+)/K(+)-ATPase is often altered in hypertrophic and failing hearts. The mechanisms are unclear. There are limited data from human cardiomyocytes. Abundant evidences from rodents show that Na(+)/K(+)-ATPase regulates cardiac contractility, cell signaling, hypertrophy and fibrosis. The α1 isoform of the Na(+)/K(+)-ATPase is the ubiquitous isoform and possesses both pumping and signaling functions. The α2 isoform of the Na(+)/K(+)-ATPase regulates intracellular Ca(2+) signaling, contractility and pathological hypertrophy. The α3 isoform of the Na(+)/K(+)-ATPase may also be a target for cardiac hypertrophy. Restoration of cardiac Na(+)/K(+)-ATPase expression may be an effective approach for prevention of cardiac remodeling. In this article, we will overview: (1) the distribution and function of isoform specific Na(+)/K(+)-ATPase in the cardiomyocytes. (2) the role of cardiac Na(+)/K(+)-ATPase in the regulation of cell signaling, contractility, cardiac hypertrophy and fibrosis in vitro and in vivo. Selective targeting of cardiac Na(+)/K(+)-ATPase isoform may offer a new target for the prevention of cardiac remodeling.
Department of Medicine, College of Medicine and Life Sciences, University of Toledo Toledo, OH, USA.
Lijun
L
Liu
Center for Craniofacial Molecular Biology, University of Southern California Los Angeles, CA, USA.
Jian
J
Wu
Department of Medicine, College of Medicine and Life Sciences, University of Toledo Toledo, OH, USA.
David J
DJ
Kennedy
Na+/K+-ATPase; cardiac remodeling; cardiomyocyte; fibrosis; hypertrophy; isoform; ouabain
J Biol Chem. 2001 Nov 9;276(45):42050-6
11562372
Hypertension. 1999 Jul;34(1):107-12
10406832
Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6259-63
1648735
FASEB J. 1990 Apr 1;4(6):1598-605
2156741
J Biol Chem. 2000 Sep 8;275(36):27832-7
10874030
PLoS One. 2013 Dec 13;8(12):e84306
24349570
J Mol Cell Cardiol. 2005 Jul;39(1):113-20
15907930
Biochim Biophys Acta. 1989 May 9;988(2):185-220
2541792
Mol Cell. 1999 May;3(5):555-63
10360172
J Mol Cell Cardiol. 1997 Nov;29(11):3157-67
9405189
J Biol Chem. 2012 May 11;287(20):16390-8
22451662
Br J Pharmacol. 2002 Feb;135(3):771-81
11834625
J Biol Chem. 2004 Aug 6;279(32):33306-14
15161929
Annu Rev Biochem. 2002;71:511-35
12045105
Cardiovasc Res. 2008 Apr 1;78(1):71-8
18203708
Am J Hypertens. 2012 Jun;25(6):690-6
22378033
J Biol Chem. 2010 Jun 18;285(25):19582-92
20388710
J Bioenerg Biomembr. 2005 Dec;37(6):387-92
16691470
Cardiovasc Res. 2007 Jan 1;73(1):92-100
17157829
Am J Physiol Heart Circ Physiol. 2013 Apr 15;304(8):H1147-58
23436327
Cell Mol Biol (Noisy-le-grand). 2001 Mar;47(2):265-71
11355000
Cell Biosci. 2015 Nov 18;5:64
26587223
J Biol Chem. 1994 Jan 14;269(2):1541-7
8288620
J Mol Cell Cardiol. 1994 May;26(5):591-600
8072013
Heart. 2009 Aug;95(15):1273-7
19443475
J Physiol. 2015 Mar 15;593(6):1361-82
25772291
Circulation. 2002 Jul 23;106(4):447-53
12135944
Front Endocrinol (Lausanne). 2014 Dec 03;5:199
25520702
J Biol Chem. 2003 Dec 26;278(52):53026-34
14559919
FASEB J. 2003 Sep;17(12):1592-608
12958166
Am J Physiol. 1998 Nov;275(5 Pt 2):F633-50
9815123
Mol Pharmacol. 2005 Mar;67(3):929-36
15602003
Am J Physiol Cell Physiol. 2003 Jun;284(6):C1550-60
12606314
J Clin Invest. 1996 Oct 1;98(7):1650-8
8833915
J Biol Chem. 1999 Jul 2;274(27):19323-8
10383443
J Hypertens. 1994 May;12(5):549-60
7930555
J Mol Cell Cardiol. 1997 Feb;29(2):429-37
9140803
Am J Physiol Cell Physiol. 2007 Jul;293(1):C321-7
17392375
J Biol Chem. 1998 Jun 12;273(24):15249-56
9614140
Circ Res. 2014 Jan 17;114(2):249-56
24218169
J Pharmacol Exp Ther. 2016 May;357(2):311-9
26941169
J Mol Cell Cardiol. 1998 Jul;30(7):1311-28
9710800
Am J Physiol Heart Circ Physiol. 2004 Nov;287(5):H2173-82
15256370
J Cardiovasc Pharmacol. 2003 Apr;41(4):609-14
12658063
Biomed Res Int. 2015;2015:714793
26609532
J Hypertens. 2005 Aug;23(8):1515-23
16003178
Hypertension. 2006 Mar;47(3):488-95
16446397
J Pharmacol Exp Ther. 2005 May;313(2):731-9
15644428
Biophys J. 2015 Nov 3;109 (9):1852-62
26536262
J Hypertens. 2015 Mar;33(3):534-41; discussion 541
25479026
Circ Res. 2008 Aug 1;103(3):279-88
18599868
Front Biosci. 2005 Sep 01;10:2018-26
15970474
Biochim Biophys Acta. 1957 Feb;23(2):394-401
13412736
J Biol Chem. 2013 Nov 22;288(47):34249-58
24121502
J Hypertens. 2015 Aug;33(8):1602-10
26136067
Am J Cardiol. 1988 Jun 1;61(15):1312-5
3376892
J Am Soc Nephrol. 2010 Sep;21(9):1550-9
20576808
Hypertension. 2014 Oct;64(4):680-3
25001271
Cardiovasc Res. 2007 Jul 1;75(1):109-17
17442282
Cardiovasc Res. 2003 Mar 15;57(4):913-20
12650869
Cardiovasc Res. 2003 Mar 15;57(4):897-912
12650868
Am J Physiol Cell Physiol. 2009 Sep;297(3):C699-705
19570895
J Physiol. 1999 Apr 15;516 ( Pt 2):377-83
10087338
Free Radic Biol Med. 2006 Nov 15;41(10):1548-56
17045923
Circ Res. 1994 Apr;74(4):669-78
8137503
J Mol Cell Cardiol. 2003 Jan;35(1):5-25
12623296
J Biol Chem. 2009 Sep 25;284(39):26749-57
19638348
J Biol Chem. 2000 Sep 8;275(36):27838-44
10874029
J Biol Chem. 2011 Jul 1;286(26):22806-13
21555512
Hypertens Res. 2000 Sep;23 Suppl:S77-85
11016824
Cardiovasc Res. 2012 Sep 1;95(4):480-6
22739122
Cardiovasc Res. 2005 Jan 1;65(1):93-103
15621037
J Biol Chem. 2016 May 27;291(22):11736-50
27022017
Proc Natl Acad Sci U S A. 2015 Feb 10;112(6):1755-60
25624492
FASEB J. 2004 Jan;18(1):197-9
14597563
Am J Physiol Renal Physiol. 2009 Apr;296(4):F922-34
19176701
Am J Physiol Cell Physiol. 2007 Nov;293(5):C1489-97
17728397
Physiol Genomics. 2016 Mar;48(3):220-9
26702050
Circulation. 2013 Oct 15;128(16):e240-327
23741058
Pharmacol Rev. 2009 Mar;61(1):9-38
19325075
Biochim Biophys Acta. 2012 May;1818(5):1269-73
22290188
Am J Physiol Heart Circ Physiol. 2005 Feb;288(2):H477-85
15458945
Am J Physiol Heart Circ Physiol. 2013 Feb 1;304(3):H427-35
23203972
Biochim Biophys Acta. 2010 Dec;1802(12):1237-45
20144708
Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):217-27
18957371
Am J Physiol Renal Physiol. 2008 Oct;295(4):F1117-25
18701625
Mol Pharmacol. 2012 Sep;82(3):500-9
22695717
Hypertension. 2007 Jan;49(1):215-24
17145984
Cardiovasc Res. 2003 Mar 15;57(4):887-96
12650867
Nature. 2003 Feb 6;421(6923):634-9
12571597
JACC Cardiovasc Imaging. 2011 Jan;4(1):98-108
21232712
Circ Heart Fail. 2015 Nov;8(6):1068-76
26276886
Clin Chim Acta. 2014 Apr 20;431:87-92
24508998
Am J Physiol Heart Circ Physiol. 2014 Sep 1;307(5):H635-9
24993043
Acta Pharmacol Sin. 2007 Mar;28(3):344-52
17302996
Eur J Biochem. 2002 May;269(10):2434-9
12027880
Am J Cardiol. 1965 Oct;16(4):534-9
4220808
Hypertension. 1997 Feb;29(2):606-12
9040446
Nephrol Dial Transplant. 2011 Sep;26(9):2912-9
21292813
Am J Physiol Heart Circ Physiol. 2011 Jan;300(1):H347-55
20952666
Toxicol Appl Pharmacol. 2005 Sep 15;207(3):244-56
16129117
Trends Cardiovasc Med. 2009 May;19(4):111-8
19818946